News

Lawxpart/New

PSU and its spinoff usher antimalarial drug to human trials

PSU and its spinoff usher antimalarial drug to human trials

An antimalarial drug developed in Portland has begun enrolling patients in its first in-human study. The investigational drug, invented at Portland State University and developed by PSU spinoff DesignMedix, is a modified form of chloroquine, an established antimalarial drug that kills the parasites once they have infected human red blood cells. Many strains of the parasites that cause the deadliest form of malaria have developed resistance to chloroquine, and the parasites can expel the drug before…

read more
The Funded: Twitch co-founder’s new legal AI startup raises $65M, biotechs line up IPOs, and more

The Funded: Twitch co-founder’s new legal AI startup raises $65M, biotechs line up IPOs, and more

Twitch co-founder Justin Kan’s new startup has raised $65 million, gained several prominent new board members and made a small acquisition of its own, TechCrunch reports. Atrium LTS uses machine learning to automate tasks for the legal industry. The San Francisco-based company “digitizes legal documents and builds applications on top to speed up fundraising, commercial contracts, equity distribution and employment issues,” according to TechCrunch. Andreessen Horowitz led the latest round,…

read more

Mr John Smith

-Customer

“Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.”

Mr John Smith

-Customer

“Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.”

Call us Free

If you would like to speak with someone directly

500.250.1234

Free Consulting